Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)" (NODAT-ES)

20 juli 2019 uppdaterad av: Nashwa Othman, Dasman Diabetes Institute

Introduction:

Diabetes is a chronic disease that requires lifelong self care behavior. Successful treatment of chronic diseases is closely associated with the education of both patients and their relatives. Patient education is one of the most important responsibilities of diabetes nurse educators. In the management of diabetes, helping patients to improve their health and quality of life is considered an important aspect of diabetes self-care education. Solid organ transplantation is now the standard of care for end-stage organ failure. New-onset diabetes mellitus after solid organ transplantation (NODAT) has emerged as an increasingly important determinant of outcomes and survival in transplant recipients. Patient education and self-management are crucial for ensuring successful outcome post transplantation. No adequate studies concerning education of diabetic renal transplants.

Aim of the work: The aim of this work is to evaluate the effect of diabetes education given to renal transplant recipients with new onset diabetes after transplantation (NODAT) on their self-care activities and metabolic control variables and reversibility of the present chronic diabetic complications.

Patients and methods:

The study will involve 210 diabetic renal transplant patients (NODAT) who will be referred from Hamed Al-Essa organ transplant center to Dasman Diabetes Institute. These patients will be sub-divided into three subgroups: patients who will receive group education (n=70) will represent group1, patients who will receive one to one education (n=70) will represent group 2, while those who will receive the conventional (not structured) education program will serve as control group 3(n= 70). All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.

Expected outcome: Patient education given to transplant recipients with NODAT could affect patients' self-care activities, metabolic control positively and possibly help in reversal of chronic diabetic complications

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

The research population will include organ transplant recipients with NODAT who are followed up in Hamed AL-Essa organ transplant centre of Kuwait and who will meet the eligibility criteria. Two hundred and ten diabetic renal transplant recipients will be enrolled in this prospective randomised controlled study. Patients who fulfil the following criteria will be included in the study: 1) transplant duration more than 6 months; 2) being an outpatient; 3) not having any psychiatric history of illness; 4) written consent to participate in the research; and 5) age of diabetic patients more than 21 years . We will exclude paediatrics (bellow 21 years) and mentally abnormal patients. Ethical principles of the research Written permission will be received from the institutions where the research will be carried out. Information form including the aim and scope of the research will be submitted to Ethical Committees of both ministry of health (MOH) of Kuwait and Dasman Diabetes Institute.

Data collection tools

Patient identification form:

This form will include information about the patient's identifying characteristics such as age, gender, education status and disease-related information such as duration of the disease and the treatments management of diabetes.

Metabolic control parameters form:

This form will include patient's metabolic control variables such as HbA1c, lipids (Total cholesterol, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL), renal and liver function tests. Metabolic control parameters will be measured in Hamed Al-Essa organ transplantation center (OTC) outpatient clinic and will be sent with each patient to Dasman Diabetes Institute within one week of patient evaluation for starting educational program.

Blood pressure, height, weight, body mass index and waist circumference of patients will be measured and recorded by the researcher each time by using the same measurement device and method. Patients' waist circumferences will be measured midway between costal margin and iliac crests by a measuring tape in standing position, over underwear and after slight expiration.

Diabetes self-care scale (DSCS) The Arabic translated 24-items scale- developed in English by Lee and Fisher(41) which measures the self care of patients with diabetes -will be applied to patients before and after the education program.

Data collection method In the pretest phase of the research, patients will be given a patient identification form, metabolic control parameters form and a DSCS. The forms will be completed within15-25 minutes by the patients in the presence of the researcher. Telephone numbers and addresses of patients will be taken for proper communication if needed.

Patient education Group education sessions will be carried out in special halls in Dasman Diabetes Institute (DDI) after proper coordination with the randomly selected patients (group 1) (6-10 patients in each education group). Patients of one to one education group (group 2) will receive education sessions individually in closed education clinics of DDI. The first session will last for 60 minutes then the next sessions will last for 30 minutes. The content of education will be repeated entirely or partly by the researcher according to each patient's needs. Mixed education techniques such as description, question and answer techniques will be used as an education method and feedback will be stimulated trying to enable patients to understand their self-care management independently. Refreshment education sessions will be delivered every 3 months later on till the end of the study.

Regarding patients of the third group (control group), each patient will receive the conventional (non-structured) education program in their mother hospital (OTC).

Studietyp

Interventionell

Inskrivning (Faktisk)

210

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Kuwait City
      • Kuwait, Kuwait City, Kuwait, 15462
        • Dasman Diabetes Institute

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

21 år till 70 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • 1) transplant duration more than 6 months; 2) being an outpatient; 3) not having any psychiatric history of illness; 4) written consent to participate in the research; and 5) age of diabetic patients more than 21 years

Exclusion Criteria:

  • pediatrics (bellow 21years) and mentally abnormal patients.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Group education for 2 years
Patients who will receive structured diabetes education in groups , Group 1
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Andra namn:
  • one to one
  • conventional education
Aktiv komparator: One to one education for 2 years
Patients who will receive one to one structured diabetes education, Group 2
All patients of group 1 and 2 will receive intensive education for 3-4 months, then refreshment session every 3 months for 2 years. Initially, patient data will be collected through 3 types of forms: patient identification form, metabolic control parameters form and diabetes self-care scale questionnaire; then every 6 months metabolic parameters and diabetes self-care scale questionnaire will be reassessed.
Andra namn:
  • one to one
  • conventional education
Inget ingripande: Control group without structured education
Patients who will not receive structured diabetes education, Group 3

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Evaluate the effect of diabetes education given to renal transplant recipients with new onset diabetes after transplantation .
Tidsram: For 2 years from the time of enrolment
Positive metabolic control and self-care diabetes management
For 2 years from the time of enrolment

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
comparison of type of diabetes education
Tidsram: For 2 years from the enrolment
Comparison between one to one vs. group education
For 2 years from the enrolment

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Nashwa F Othman, MD PhD, Senior diabetes educator in Dasman Diabetes Institute
  • Studierektor: Osama A Gheith, MD PhD, Consultant nephrologist, Hamed Al-Essa organ transplnat center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 maj 2015

Primärt slutförande (Faktisk)

1 juni 2018

Avslutad studie

1 juli 2019

Studieregistreringsdatum

Först inskickad

15 mars 2017

Först inskickad som uppfyllde QC-kriterierna

20 juli 2019

Första postat (Faktisk)

23 juli 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

23 juli 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

20 juli 2019

Senast verifierad

1 juli 2019

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera